Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-25 @ 1:08 AM
NCT ID:
NCT00674193
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of cancer, including, but not limited to, any of the following:
* Acute lymphoblastic leukemia
* Ewing sarcoma
* Rhabdomyosarcoma
* Soft tissue sarcoma
* Wilms tumor
* Due to receive or receiving dactinomycin and/or vincristine as a component of cancer treatment on another clinical trial
* Able to comply with study requirements
* Other concurrent chemotherapeutic agents allowed
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
16 Years
Study:
NCT00674193
Study Brief:
Protocol Section:
NCT00674193